DB
HURA

Danske Bank’s TuHURA Biosciences HURA Stock Holding History

Danske Bank’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
1
– – ﹤0.01% 1125
2026
Q1 		$2 Buy
+1
New +$1 ﹤0.01% 1152

Other funds holding HURA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WP
WealthShield Partners Cary, North Carolina $654M AUM 26.48% 1-Year Est. Return

Danske Bank's HURA Position: Q2 2026 in Review

Danske Bank held its TuHURA Biosciences (HURA) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #1125.

Danske Bank first reported a position in HURA in Q1 2026 and has held it in 2 quarters since. 63 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Danske Bank held 1 share of TuHURA Biosciences worth $2 as of Q2 2026.
  • Danske Bank left its TuHURA Biosciences share count unchanged in Q2 2026.
  • TuHURA Biosciences made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1125 holding.
  • Danske Bank first reported a position in TuHURA Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 63 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.